KATHLEEN VERPAELE: Open Payments
NPI 1942446885 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 18 payments from 11 companies in 2025. Trend: 2023 $443 · 2024 $631 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $109 |
| GENZYME CORPORATION | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Phathom Pharmaceuticals, Inc. | 1 | $68 |
| Novo Nordisk Inc | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
Products named: DUPIXENT, VOQUEZNA, COSENTYX, Wegovy, NUZYRA, Rhapsido, BOTOX, SKYRIZI.
Industry payments across FL — which companies pay providers there.
